Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2.
Tassaneeyakul
W
W
Department of Clinical Pharmacology, Flinders Medical Centre, Adelaide, Australia.
Birkett
D J
DJ
Veronese
M E
ME
McManus
M E
ME
Tukey
R H
RH
Miners
J O
JO
D000818:Animals; D002460:Cell Line; D019388:Cytochrome P-450 CYP1A2; D065607:Cytochrome P-450 Enzyme Inhibitors; D006801:Humans; D007700:Kinetics; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
D065607:Cytochrome P-450 Enzyme Inhibitors; D013806:Theophylline; C050131:furafylline; D010088:Oxidoreductases; D019388:Cytochrome P-450 CYP1A2